RecruitingNot Applicable

Transient Pseudohypoaldosteronism Affecting Children With Urinary Tract Malformation

France50 participantsStarted 2024-01-31

Plain-language summary

Pseudohypoaldosteronism is a pathology affecting children under 6 months of age, little known but which can have serious consequences. There are no real figures on the prevalence of this pathology in France. The exact pathophysiology is not known and the management is not currently codified. This is why it is interesting to study this pathology and its treatment on a national scale in order to think about the best possible treatment, as well as to raise awareness of this pathology among different health professionals.

Who can participate

Age range1 Year – 6 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Minor subjects aged less than 6 years at the time of diagnosis * Diagnosis of pseudohypoaldosteronism in the context of urinary malformation and/or urinary infection between January 1, 2018 and December 31, 2023 * Subject (and/or their parental authority) having not expressed, after information, their opposition to the reuse of their data for the purposes of this research. Exclusion Criteria: * Subject (or their parents) having expressed their (their) opposition to participating in the study

What they're measuring

National comparison of clinical and therapeutic practices concerning the management of pseudohypoaldosteronism in children with urinary malformations and/or urinary infections

Timeframe: Up to 1 year

Trial details

NCT IDNCT06905600

SponsorUniversity Hospital, Strasbourg, France

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-12

Contact for this trial

Ariane ZALOSZYC, MD

33 3 88 12 77 42 ariane.zaloszyc@chru-strasbourg.fr

View on ClinicalTrials.gov More Pseudohypoaldosteronism trials